The Waltham, Mass., science outfit made $49 million, or 30 cents a share, for the quarter ended Sept. 30, up from the year-ago continuing operations profit of $41 million, or 25 cents a share. On an adjusted basis, excluding certain items, latest-quarter earnings rose to 44 cents from 38 cents a year ago. Sales rose to $725 million from $679 million a year earlier.
Analysts were looking for a 43-cent profit on sales of $711 million.
The company, which is in the midst of a merger with
, said it now expects to make $1.74 to $1.77 for the year, up from previous guidance of $1.68 to $1.73. Analysts were looking for $1.75.